中药ETF(560080)标的指数成分股多数飘红：达仁堂涨超4%，片仔癀涨超3%，同仁堂涨超2%，云南白药、华润三九涨超1%，东阿阿胶、白云山、众生药业 微涨。 | 序号 | 代码 | 名称 | 估算权重 ▼ | 涨跌幅 | 服交零售负 | | --- | --- | --- | --- | --- | --- | | 1 | 000538 | 云南自药 | 10.56% | 1.47% | 7.26亿 | | 2 | 600436 | 片仔瘦 | 9.21% | 3.78% | 13.06亿 | | 3 | 000423 | 东阿阿胶 | 6.18% | 0.73% | 6.13亿 | | 4 | 600085 | 同仁堂 | 5.18% | 2.05% | 5.51亿 | | ਦੇ | 0009999 | 华润三九 | 4.76% | 1.52% | 5.76 Z | | 6 | 000623 | 吉林敖东 | 4.65% | -1.05% | 2.47 亿 | | 7 | 600332 | 日六日 | 4.28% | 0.43% | 3.15亿 | | 8 | 002603 | 以岭药业 | 3.65% ...

从资金流向上来看，当日中药板块主力资金净流入7067.51万元，游资资金净流出1.31亿元，散户资金净 流入6030.46万元。中药板块个股资金流向见下表： | 代码 | 名称 | 主力净流入(元) | 主力净占比 游资净流入 (元) | | 游资净占比 散户净流入 (元) | | 散户净占比 | | --- | --- | --- | --- | --- | --- | --- | --- | | 600436 | 片仔瘦 | 7033.61万 | 11.36% | -554.04万 | -0.89% | -6479.57万 | -10.47% | | 600518 | 康美药业 | 3587.72万 | 12.09% | -2642.43万 | -8.90% | -945.29万 | -3.19% | | 600085 | 同仁堂 | 3340.39万 | 9.95% | -1916.58万 | -5.71% | -1423.81万 | -4.24% | | 603858 | 步长制药 | 3071.09万 | 16.61% | -96.93万 | -0.52% | -2974.16万 | -16.09% ...

近日，云南白药（000538）发布公告称，公司近日接到股东新华都（002264）实业集团的通知，获悉新 华都将其持有的公司部分股份办理了质押。 公告显示，新华都及其一致行动人持有云南白药股份数量为449,624,311股，本次质押股数为675万股， 占新华都及其一致行动人所持股份比例为1.50%，占云南白药总股本比例为0.38%；合计累计被质押股 数为80,250,000股，占新华都及其一致行动人所持股份比例为17.85%，占云南白药总股本比例为 4.50%。 ...

云南白药集团股份有限公司（以下简称"公司"或"云南白药"）于近日接到公司股东新华都实业集团股份 有限公司（以下简称"新华都"）的通知，获悉新华都将其持有的公司部分股份办理了质押。具体情况如 下： 一、本次股份质押基本情况 ■ 登录新浪财经APP 搜索【信披】查看更多考评等级 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 三、其他说明 质押股份是否负担重大资产重组等业绩补偿义务：否。 二、股东股份累计质押情况 截至本公告披露日，新华都及其一致行动人所持质押股份情况如下： ■ 注：1、新华都持股数量、持股比例、质押股份数量等相关数据，均考虑了新华都通过非公开发行可交 换公司债券开立的"新华都集团-国信证券-25新华都EB01担保及信托财产专户"所持有的云南白药股份 5,600万股； 2、除上述担保及信托专户外，新华都的一致行动人所持云南白药股份均不存在质押情形。 截至本公告披露日，新华都及其一致行动人持有云南白药股份数量为449,624,311股，本次质押股数为 6,750,000股，占新华都及其一致行动人所持股份比例为1.50%，占云南白药总股本比例为0.38 ...

质押股份是否负担重大资产重组等业绩补偿义务：否。 1 / 3 股票代码：000538 股票简称：云南白药 公告编号：2026-02 云南白药集团股份有限公司 关于股东部分股份质押的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 云南白药集团股份有限公司（以下简称"公司"或"云南白药"）于近 日接到公司股东新华都实业集团股份有限公司（以下简称"新华都"）的通 知，获悉新华都将其持有的公司部分股份办理了质押。具体情况如下： 股东名 称 是否为控 股股东或 第一大股 东及其一 致行动人 本次质押数 量（股） 占其所 持股份 比例 占公司 总股本 比例 是否为限 售股（如 是，注明 限 售 类 型） 是否 为补 充质 押 质押起始日 质押 到期 日 质权人 质押 用途 新华都 实业集 团股份 有限公 司 否 6,750,000 1.55% 0.38% 否 否 2026-02-02 至办 理解 除质 押之 日止 兴业银 行股份 有限公 司福州 分行 融资 担保 合计 / 6,750,000 1.55% 0.38% / / / / / / 一、本次股份质押基本情况 ...

证券之星消息，2月3日中药板块较上一交易日上涨0.73%，佛慈制药领涨。当日上证指数报收于 4067.74，上涨1.29%。深证成指报收于14127.1，上涨2.19%。中药板块个股涨跌见下表： | 代码 | 名称 | 主力净流入(元) | 主力净占比 游资净流入(元) | | 游资净占比 散户净流入 (元) | | 散户净占比 | | --- | --- | --- | --- | --- | --- | --- | --- | | 603858 | 步长制药 | 4205.73万 | 18.61% | -760.51万 | -3.37% | -3445.23万 | -15.25% | | 000538 | 云南白药 | 2312.47万 | 6.02% | 2001.01万 | 5.21% | -4313.47万 | -11.23% | | 600572 | 康恩贝 | 1733.96万 | 9.84% | 908.52万 | 5.16% | -2642.49万 | -15.00% | | 002644 | 佛慈制药 | 1463.40万 | 4.66% | 701.64万 | 2.23% | -2165 ...

Core Viewpoint - The article emphasizes the importance of health and wellness, particularly for individuals over 40, highlighting the need to take care of oneself to support family responsibilities and well-being [5][8][9]. Group 1: Health and Wellness - Individuals over 40 who have healthy parents and a stable family are considered to be at the top of the social pyramid [5]. - Taking care of one's health is not just a personal matter but a significant concern for the entire family [9]. - True wellness is described as a long-term commitment rather than a temporary trend or luxury [11]. Group 2: Yunnan Baiyao Brand - Yunnan Baiyao is presented as a century-old national brand, established in 1902, known for its quality and trustworthiness [15][16]. - The brand has a rich history, having been recognized and supported by historical figures, including Premier Zhou Enlai [18]. - Yunnan Baiyao's products are based on a secret formula that has been validated by generations of users, establishing a strong reputation [21]. Group 3: Product Offerings - The article promotes various health products, including broken wall ganoderma spore powder, western ginseng, and saffron, available at discounted prices during a live broadcast event [13][28]. - The broken wall ganoderma spore powder is highlighted for its high bioavailability and health benefits, including immune support and anti-aging properties [40][41]. - The article also mentions the three-seven powder, which is known for its blood circulation benefits, and emphasizes its quality through rigorous testing [54][56]. Group 4: Promotional Event - A promotional live broadcast event is scheduled for February 4, featuring significant discounts on health products, encouraging early reservations [27][28]. - The event aims to provide affordable health solutions, with prices as low as 9.9 yuan for certain products, making them accessible to a wider audience [28][29]. - The article encourages participation in the live event to secure exclusive offers and learn about the products from experts [27][76].

内容概况：妇科用药是对预防、诊断、治疗妇科类疾病的各类药物的统称。近年来，随着妇科疾病发病 率的增加、女性健康意识的提高以及医疗技术的进步，针对妇科疾病的药物研发和治疗方案变得更加多 样化和个性化。现代妇科用药不仅限于传统的激素类药物，还包括了抗感染药物、止痛剂、免疫调节剂 等多种类型，满足了不同妇科疾病的需求。同时，非处方药的增多和线上购药平台的兴起，使患者获取 药物更加便捷，提升了用药的可及性和安全性。在此背景下，国内妇科用药市场规模持续保持高速增 长。数据显示，中国妇科用药行业市场规模从2012年的277.35亿元增长至2024年的561.37亿元，年复合 增长率为6.05%。2025年中国妇科用药行业市场规模约为595.3亿元。未来，随着女性健康意识的增强和 社会对女性健康的重视程度不断提高，妇科用药市场将呈现出稳步增长的趋势。 相关上市企业：千金药业（600479）、同仁堂（600085）、康缘药业（600557）、九芝堂（000989）、 云南白药（000538）、新天药业（002873）、华润三九（000999）、康弘药业（002773）、振东制药 （300158）、盘龙药业（002864）等。 ...

Core Insights - The pharmaceutical industry is increasingly adopting AI technologies, with over 60% of pharmaceutical companies and more than half of public hospitals using DingTalk as an AI operating system to enhance productivity [1][2] - AI is transforming the pharmaceutical sector by enabling companies to shift from repetitive tasks to more strategic roles, thereby enhancing operational efficiency [1][2] - DingTalk's AI application white paper indicates that AI is moving from exploration to large-scale application across the pharmaceutical value chain, impacting drug discovery, production, quality control, and patient services [1][2] Industry Developments - The pharmaceutical industry is characterized by high specialization, strong regulation, and long supply chains, making AI implementation a systemic transformation rather than just a technological upgrade [2] - DingTalk's AI solutions have been successfully implemented in various pharmaceutical companies, including WuXi AppTec and Innovent Biologics, and the company plans to launch a "Digital Pioneer Competition" to cultivate AI-savvy individuals within 100 pharmaceutical firms [2][3] - The establishment of the "Pharmaceutical Industry AI Innovation Alliance" aims to address common challenges such as data governance and ethical standards, promoting best practices for AI development in the sector [2][3] Company Case Studies - WuXi AppTec and DingTalk have developed a digital foundation called "BaiYaoDing," integrating AI into various processes, including traditional Chinese medicine traceability and smart factory production [2][3] - Innovent Biologics focuses on fine management in production through AI, achieving digitalization and transparency in anomaly handling, which has led to significant labor savings and improved quality [3] - Lepu Medical's AI initiatives provide 24/7 professional knowledge support to sales teams, resulting in a 200% return on AI investment by 2025, demonstrating AI's direct value in driving business growth [3] - Xianle Health has utilized AI tools to create an intelligent inspection application, enhancing management efficiency and fostering a culture of innovation within the organization [3][4] Future Outlook - AI is becoming a core driver of quality improvement, efficiency, and innovation in the pharmaceutical industry, with ongoing advancements in technology and a thriving ecosystem [4]

不仅如此，云南的全国民族团结进步模范、示范区(单位)数量均居第一方阵。"十四五"时期，云南持续 深化民族团结进步示范区建设，累计建成363个民族团结进步示范社区。 一家企业也登上"世界之巅"——云南白药成为全球中医药健康品领域首座"灯塔工厂"。"灯塔工厂"是由 达沃斯世界经济论坛评选，代表全球制造业领域智能制造和数字化最高水平的示范性生产工厂。 云南省第十四届人民代表大会第四次会议在昆明市开幕。中新网记者 刘冉阳 摄 云南素有"有色金属王国"的美称，分量最重的巅峰时刻便来自稀贵金属产业：锡铟锗产量全球第一，形 成中国最完整的铂族金属和钛产业链。此外，滇中稀贵金属集群，成为行业内唯一的国家级先进制造业 集群。 云南是中国农业大省，正向高原特色农业强省发展，生态农业、设施农业、高效农业、共享农业不断壮 大。在此过程中，云南多项数据站在全球、中国之巅：花卉产量全球第一，优质鲜切花占比60%；有机 产品认证证书数居中国第一；茶叶、咖啡、坚果、天然橡胶等产量连年位居全国第一。 作为中国生态文明建设排头兵，"十四五"时期，云南积极践行"两山"理念，坚定不移走生态优先、绿色 发展之路，不断攀登"巅峰"：文明健康绿色环保生活 ...